Why the study?
Does intensive medical therapy with cimetidine and antacids heal aspirin-associated peptic ulcers in patients with rheumatic disease who continue aspirin therapy?
Does intensive medical therapy with cimetidine and antacids heal aspirin-associated peptic ulcers in patients with rheumatic disease who continue aspirin therapy?
Intensive medical therapy aimed at lowering intragastric acidity can heal aspirin-associated peptic ulcers even when aspirin therapy is continued.
Intensive acid suppression may heal aspirin ulcers despite continued use; case report leaves open need for randomized confirmation.
Patients who have rheumatic disease and who are undergoing long-term aspirin therapy have a high incidence of peptic ulcer disease. Whether it is possible to heal long-term aspirin-related peptic ulcer disease if aspirin intake is continued is unknown. Nine patients with rheumatic disease who were receiving long-term aspirin therapy and who had 15 endoscopically verified gastric and/or duodenal ulcers were studied. Patients were treated daily with 1,200 mg of cimetidine plus at least 120 mL of antacid (Mylanta II), while continuing aspirin therapy at the same dose and type. By eight weeks, 14 ulcers had healed. This study shows that some aspirin-associated peptic ulcers can be healed, despite continued aspirin intake, by intensive medical therapy aimed at lowering intragastric acidity.
No takes yet. Share an insight, caveat, or question.
Joseph C. O’Laughlin (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: